Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Bioanalysis|February 9, 2019
Direct quantitation of therapeutic antibodies for pharmacokinetic studies using immuno-purification and intact mass analysisLisa A Vasicek, Xin Zhu, Daniel S Spellman, et al.Journal of the American Society for Mass Spectrometry|April 3, 2009
Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometerKevin P Bateman, Markus Kellmann, Helmut Muenster, et al.Journal of Pharmaceutical Sciences|March 18, 2018
Microdosing Cocktail Assay Development for Drug-Drug Interaction StudiesCynthia M Chavez-Eng, Ryan W Lutz, Dina Goykhman, et al.Rapid Communications in Mass Spectrometry : RCM|August 18, 2005
'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switchingMark Wrona, Timo Mauriala, Kevin P Bateman, et al.Rapid Communications in Mass Spectrometry : RCM|June 15, 2005
A strategy for identification of drug metabolites from dried blood spots using triple-quadrupole/linear ion trap hybrid mass spectrometryTimo Mauriala, Nathalie Chauret, Renata Oballa, et al.Bioanalysis|November 3, 2017
Using miniature MS system with automatic blood sampler for preclinical pharmacokinetics studyFan Pu, Wenpeng Zhang, Kevin P Bateman, et al.Rapid Communications in Mass Spectrometry : RCM|February 10, 2025
Molecular Structure and Mass Spectral Data Quality-Driven Processing of High-Resolution Mass Spectrometry for Quantitative AnalysisFabien Fontaine, Luca Morettoni, Ken Anderson, et al.Bioanalysis|June 29, 2018
Top-down LC-MS quantitation of intact denatured and native monoclonal antibodies in biological samplesLiyun Zhang, Lisa A Vasicek, SuChun Hsieh, et al.Rapid Communications in Mass Spectrometry : RCM|April 22, 2006
Simultaneous analysis of prostanoids using liquid chromatography/high-field asymmetric waveform ion mobility spectrometry/tandem mass spectrometryJames Kapron, Jin Wu, Timo Mauriala, et al.Bioanalysis|February 12, 2013
Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and howYang Xu, Eric J Woolf, Nancy Gb Agrawal, et al.Pageof 6